Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - Tempus AI reported a revenue of $334.21 million for the quarter ended September 2025, reflecting an 84.7% increase year-over-year and a 2.38% surprise over the Zacks Consensus Estimate of $326.43 million [1] - The company's EPS was -$0.11, an improvement from -$0.25 in the same quarter last year, with a surprise of +31.25% compared to the consensus estimate of -$0.16 [1] Revenue Breakdown - Net Revenue from Data and Services was $81.33 million, slightly below the average estimate of $81.6 million from five analysts [4] - Net Revenue from Genomics reached $252.88 million, exceeding the average estimate of $244.82 million from five analysts [4] Profitability Metrics - Non-GAAP Gross Profit from Genomics was reported at $155.9 million, surpassing the estimated $141.1 million from three analysts [4] - Non-GAAP Gross Profit from Data and Services was $56.66 million, falling short of the estimated $60.07 million from three analysts [4] Stock Performance - Over the past month, Tempus shares have returned -4.7%, contrasting with the Zacks S&P 500 composite's +2.1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]